Rigel Pharmaceuticals (RIGL) Operating Expenses (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Operating Expenses of $46.9 million for Q1 2026, up 15.71% year-over-year from $40.6 million in Q1 2025, and up 0.65% quarter-over-quarter from $46.6 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Operating Expenses (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Operating Expenses history runs 17 years deep, the most recent figure standing at $46.9 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 15.71% year-over-year to $46.9 million; the TTM figure through Mar 2026 stood at $175.2 million (up 10.08% YoY), while the FY2025 annual figure was $168.8 million, up 8.85% from the prior year.
- Operating Expenses for Q1 2026 stood at $46.9 million, up from $46.6 million in the prior quarter.
- The five-year high for Operating Expenses was $49.2 million in Q4 2022, with the low at $32.2 million in Q2 2023.
- The 5-year median for Operating Expenses is $40.8 million (2022), against an average of $40.2 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 31.25% in 2023, then climbed 26.54% in 2024.
- Rigel Pharmaceuticals' Operating Expenses stood at $49.2 million in 2022, then slumped by 31.25% to $33.8 million in 2023, then gained by 21.03% to $40.9 million in 2024, then rose by 13.9% to $46.6 million in 2025, then rose by 0.65% to $46.9 million in 2026.
- Business Quant data shows RIGL's Operating Expenses at $46.9 million in Q1 2026, $46.6 million in Q4 2025, and $41.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 55.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.13 Mn |
| Mar 31, 2026 | 46.93 Mn |
| Dec 31, 2025 | 46.63 Mn |
| Sep 30, 2025 | 41.04 Mn |
| Jun 30, 2025 | 40.58 Mn |
| Mar 31, 2025 | 40.56 Mn |
| Dec 31, 2024 | 40.94 Mn |
| Sep 30, 2024 | 41.25 Mn |
| Jun 30, 2024 | 36.39 Mn |
| Mar 31, 2024 | 36.50 Mn |
| Dec 31, 2023 | 33.83 Mn |
| Sep 30, 2023 | 32.60 Mn |
| Jun 30, 2023 | 32.15 Mn |
| Mar 31, 2023 | 38.80 Mn |
| Dec 31, 2022 | 49.20 Mn |
| Sep 30, 2022 | 40.81 Mn |
| Jun 30, 2022 | 42.78 Mn |
| Mar 31, 2022 | 43.00 Mn |
| Dec 31, 2021 | 41.83 Mn |
| Sep 30, 2021 | 41.33 Mn |